Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16686706rdf:typepubmed:Citationlld:pubmed
pubmed-article:16686706lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0138741lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0194810lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0475276lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C0392752lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:16686706lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:16686706pubmed:issue6lld:pubmed
pubmed-article:16686706pubmed:dateCreated2006-5-11lld:pubmed
pubmed-article:16686706pubmed:abstractTextAuthors from the USA sought to establish the relationship between tumour volume, pathological stage and outcomes after radical prostatectomy. In a large series of patients they found that tumour volume was correlated directly with pathological stage, and that it was independently correlated with PSA recurrence. The authors suggested that tumour volume had a potential use for prognostication in patients undergoing radical prostatectomy. Two papers, one from the USA and one from Germany, advise a re-staging TUR in patients with superficial bladder cancer who are at high risk of early tumour progression. In a large series of patients they found that residual tumour after initial resection was commoner than might be expected, and that the second resection indicated the way to earlier radical treatment and a better prognosis.lld:pubmed
pubmed-article:16686706pubmed:languageenglld:pubmed
pubmed-article:16686706pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16686706pubmed:citationSubsetIMlld:pubmed
pubmed-article:16686706pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16686706pubmed:statusMEDLINElld:pubmed
pubmed-article:16686706pubmed:monthJunlld:pubmed
pubmed-article:16686706pubmed:issn1464-4096lld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:ChangSam SSSlld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:WellsNancyNlld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:CooksonMichae...lld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:SmithJoseph...lld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:ShappellScott...lld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:NelsonBradfor...lld:pubmed
pubmed-article:16686706pubmed:authorpubmed-author:FarnhamScott...lld:pubmed
pubmed-article:16686706pubmed:issnTypePrintlld:pubmed
pubmed-article:16686706pubmed:volume97lld:pubmed
pubmed-article:16686706pubmed:ownerNLMlld:pubmed
pubmed-article:16686706pubmed:authorsCompleteYlld:pubmed
pubmed-article:16686706pubmed:pagination1169-72lld:pubmed
pubmed-article:16686706pubmed:dateRevised2006-7-18lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:meshHeadingpubmed-meshheading:16686706...lld:pubmed
pubmed-article:16686706pubmed:year2006lld:pubmed
pubmed-article:16686706pubmed:articleTitleTumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.lld:pubmed
pubmed-article:16686706pubmed:affiliationDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA. Bradford.nelson@vanderbilt.edulld:pubmed
pubmed-article:16686706pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16686706lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16686706lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16686706lld:pubmed